AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 258: H1427-H1431, 1990;
0363-6135/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granger, J. P.
Right arrow Articles by La Rock, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granger, J. P.
Right arrow Articles by La Rock, M. J.

AJP - Heart and Circulatory Physiology, Vol 258, Issue 5 1427-H1431, Copyright © 1990 by American Physiological Society

ARTICLES

Effects of long-term increases in plasma ANP on angiotensin II-induced hypertension

J. P. Granger, E. H. Blaine, D. L. Stacy and M. J. La Rock
Department of Physiology, Eastern Virginia Medical School, Norfolk 23501.

In vitro studies have suggested that atrial natriuretic peptide (ANP) is a potent antagonist of the vasoconstrictor actions of angiotensin II (ANG II). The purpose of this study was to determine the long-term effects of physiological increases in circulating levels of ANP on arterial pressure (AP) regulation in conscious dogs (n = 9) with ANG II-induced hypertension. Infusion of ANG II at a rate of 10 ng.kg-1.min-1 for 7 days increased AP from 85 +/- 3 to 133 +/- 4 mmHg. This increase in AP was associated with an increase in total peripheral resistance (TPR) and a decrease in cardiac output (CO). After 7 days of ANG II infusion, ANP103-126 was then infused simultaneously at a rate of 20 ng.kg-1.min-1 for 7 days. Plasma levels of ANP increased from 59 +/- 15 to 285 +/- 28 pg/ml. Increasing plasma ANP levels for 7 days had no significant long-term effect on AP (133 +/- 4 vs. 125 +/- 6 mmHg), TPR, or CO. There were also no significant changes in glomerular filtration rate or sodium excretion during the 7 days of ANP infusion. These data indicate that long-term increases in circulating levels of ANP have minimal chronic hypotensive effects in dogs with ANG II hypertension. In addition, the results from this study suggest that physiological increases in plasma ANP do not exhibit long-term antagonistic effects toward the vasoconstrictor actions of ANG II.


This article has been cited by other articles:


Home page
 HypertensionHome page
J. D. Imig, X. Zhao, C. Z. Zaharis, J. J. Olearczyk, D. M. Pollock, J. W. Newman, I.-H. Kim, T. Watanabe, and B. D. Hammock
An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension
Hypertension, October 1, 2005; 46(4): 975 - 981.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online